HIVandHepatitis.com
 Google Custom Search

HCV - Liver Cirrhosis

Sustained Virological Response to Interferon-based Therapy Slows Progression of Liver Cirrhosis in Hepatitis C Patients
11-24-09

Coffee Slows Progression of Liver Disease in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis

10-23-09

Hepatitis C May Not Increase Mortality among Patients Who Are Not Coinfected, Do Not Drink Heavily, and Do Not Have Cirrhosis
9-25-09

Bone Loss and Vitamin D Deficiency Are Common among People with Liver Cirrhosis
9-01-2009

Diets High in Protein and Cholesterol May Increase Risk of Liver Cirrhosis and Cancer, while Carbohydrates May Be Protective
8-7-2009

Pegylated Interferon alfa-2b (PegIntron) Maintenance Monotherapy May Reduce Esophageal Varices in Hepatitis C Patients with Cirrhosis
5-5-09

Liver Disease Progression and Treatment Response in Latino and Asian Patients with Chronic Hepatitis C
12-12-08


Selected Hepatitis C Patients with Decompensated Cirrhosis Can Benefit from Interferon-based Therapy prior to Liver Transplantation
6-10-08


Natural History of HCV-Related Cirrhosis after Liver Transplantation

5-08-08


Pegylated Interferon plus Ribavirin for Patients with HCV-related Liver Cirrhosis

3-11-08

Non-Invasive Ways to Assess Liver Disease: Studies Test Alternatives to Liver Biopsy
2-05-08


Human Genetic Variation May Protect Against HCV-related Liver Disease Progression
1/04/08


Non-invasive FibroTest and FibroScan Predict Liver Cirrhosis Better than Earlier Stages of Fibrosis in Hepatitis C Patients
12/11/07


CD4 Cell Count Preferred over CD4 Cell Percentage for Monitoring HIV Disease Progression in
People with Cirrhosis  
8/21/07

Treatment with Pegasys Plus Ribavirin in Genotype 2/3 Chronic Hepatitis C Patients with Liver Cirrhosis  
5/22/07

Transient Elastography as a Non-invasive Method for Predicting Portal Hypertension in Patients with Hepatitis C-related Cirrhosis
5/18/07


Racial Disparities in Treatment of Patients with Cirrhosis and Complications of Portal Hypertension
5/15/07


Sustained Response to Interferon Monotherapy Reduces Rates of Liver Cancer and Death in Patients with HCV-related Cirrhosis
3/27/07